| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0002-9149(98)00872-8 |
| P698 | PubMed publication ID | 10072227 |
| P50 | author | Thor Ueland | Q12006168 |
| Stig Frøland | Q14476173 | ||
| Terje Espevik | Q15734296 | ||
| Ole A. Andreassen | Q31229142 | ||
| Pål Aukrust | Q47504859 | ||
| Lars Gullestad | Q63256598 | ||
| P2093 | author name string | F Müller | |
| S Simonsen | |||
| K Bendtzen | |||
| E Lien | |||
| I Nordøy | |||
| H Aass | |||
| P2860 | cites work | Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex | Q24316473 |
| Interleukin-10 | Q28263225 | ||
| Transforming growth factor beta (TGF-?) in inflammation: A cause and a cure | Q35226955 | ||
| Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors | Q36230900 | ||
| Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo | Q37031936 | ||
| Cytokines and natural regulators of cytokines | Q40517613 | ||
| Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines | Q40726747 | ||
| Cytokines oncostatin M and interleukin 1 regulate the expression of the IL-6 receptor (gp80, gp130). | Q41314236 | ||
| The release of soluble p55 TNF receptor from U937 cells studied by a new p55 immunoassay | Q41534330 | ||
| The role of cytokines in disease progression in heart failure. | Q41550589 | ||
| Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees | Q42942649 | ||
| Production of hybridoma growth factor by human monocytes. | Q52827130 | ||
| Tumor Necrosis Factor Soluble Receptors in Patients With Various Degrees of Congestive Heart Failure | Q57951046 | ||
| Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD) | Q59192167 | ||
| Mediation of cardioprotection by transforming growth factor-beta | Q68467347 | ||
| Elevated circulating levels of tumor necrosis factor in severe chronic heart failure | Q68524243 | ||
| Interleukin-10 inhibits the induction of monocyte procoagulant activity by bacterial lipopolysaccharide | Q70493710 | ||
| Elevated circulating levels of beta 2-microglobulin in patients with idiopathic dilated cardiomyopathy | Q70529553 | ||
| Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart | Q71102878 | ||
| Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension | Q71606973 | ||
| Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes | Q71785177 | ||
| Specific binding of interleukin 1 (IL-1) beta and IL-1 receptor antagonist (IL-1ra) to human serum. High-affinity binding of IL-1ra to soluble IL-1 receptor type I | Q72327466 | ||
| Cytokines and cardiac contractile function | Q73120047 | ||
| Elevated circulating levels of C-C chemokines in patients with congestive heart failure | Q74428129 | ||
| Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats | Q74522770 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dilated cardiomyopathy | Q283656 |
| congestive heart failure | Q19000661 | ||
| Idiopathic dilated cardiomyopathy | Q63878253 | ||
| P304 | page(s) | 376-382 | |
| P577 | publication date | 1999-02-01 | |
| P1433 | published in | American Journal of Cardiology | Q2208417 |
| P1476 | title | Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy | |
| P478 | volume | 83 |
| Q40386708 | A Study of TNF Pathway Activation in Schizophrenia and Bipolar Disorder in Plasma and Brain Tissue |
| Q24647087 | A study to assess the effects of a broad-spectrum immune modulatory therapy on mortality and morbidity in patients with chronic heart failure: the ACCLAIM trial rationale and design |
| Q74394356 | Activation of the cardiac interleukin-6 system in advanced heart failure |
| Q37297364 | Acute heart failure: patient characteristics and pathophysiology |
| Q84563836 | Altered expression of pro- and anti-inflammatory cytokines is associated with reduced cardiac function in rats following coronary microembolization |
| Q36313661 | Ameliorated stress related proteins are associated with improved cardiac function by sarcoplasmic reticulum calcium ATPase gene transfer in heart failure |
| Q34960697 | Antiinflammatory autoimmune cellular responses to cardiac troponin I in idiopathic dilated cardiomyopathy |
| Q59328888 | Are macrophages involved in early myocardial reperfusion injury? |
| Q90282403 | Arrhythmogenic mechanisms of obstructive sleep apnea in heart failure patients |
| Q50477477 | Association between serum total antioxidant status and coronary microvascular function in idiopathic dilated cardiomyopathy. |
| Q33721279 | Associations between Interleukin-31 Gene Polymorphisms and Dilated Cardiomyopathy in a Chinese Population. |
| Q37442709 | Biomarkers of inflammation in heart failure |
| Q34973559 | Blood gene expression signatures associate with heart failure outcomes |
| Q44917573 | C-reactive protein in acute myocardial infarction: association with heart failure |
| Q35990040 | Candidate-based proteomics in the search for biomarkers of cardiovascular disease |
| Q52332852 | Cardiac (myo)fibroblasts modulate the migration of monocyte subsets. |
| Q26744140 | Cardiac cachexia: hic et nunc |
| Q44631137 | Cardiac expression of urocortin (Ucn) in diseased heart; preliminary results on possible involvement of Ucn in pathophysiology of cardiac diseases |
| Q38046798 | Cardiac intercellular communication: are myocytes and fibroblasts fair-weather friends? |
| Q73888332 | Cardiopulmonary alterations in mRNA expression for interleukin-1beta, the interleukin-6 superfamily and CXC-chemokines during development of postischaemic heart failure in the rat |
| Q39542085 | Cardiotrophin-1 induces tumor necrosis factor alpha synthesis in human peripheral blood mononuclear cells |
| Q28211327 | Chronic heart failure and the immune system |
| Q37076069 | Circulating Levels of IL-6 Receptor and gp130 and Long-Term Clinical Outcomes in ST-Elevation Myocardial Infarction |
| Q63440933 | Circulating proinflammatory cytokines and N-terminal pro-brain natriuretic peptide significantly decrease with recovery of left ventricular function in patients with dilated cardiomyopathy |
| Q73931217 | Circulating soluble gp130, soluble IL-6R, and IL-6 in patients undergoing cardiac surgery, with or without extracorporeal circulation |
| Q90041312 | Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy |
| Q43957432 | Comparison of effects of carvedilol versus metoprolol on cytokine levels in patients with idiopathic dilated cardiomyopathy |
| Q53132625 | Cytokine expression in peripheral blood mononuclear cells of dogs with mitral valve disease. |
| Q81540101 | Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failure |
| Q74775107 | Cytokines and anti-cytokine therapeutic approaches to chronic heart failure |
| Q39900053 | Cytokines and matrix metalloproteinases as potential biomarkers in chronic heart failure |
| Q33863961 | Cytokines and their receptors in cardiovascular diseases--role of gp130 signalling pathway in cardiac myocyte growth and maintenance |
| Q24799394 | Cytokines as new treatment targets in chronic heart failure |
| Q34774468 | Cytokines, apoptosis and cachexia: the potential for TNF antagonism |
| Q39717737 | Decreased myocardial expression of dystrophin and titin mRNA and protein in dilated cardiomyopathy: possibly an adverse effect of TNF-alpha |
| Q89606657 | Diaphragm weakness and proteomics (global and redox) modifications in heart failure with reduced ejection fraction in rats |
| Q74598927 | Effect of aerobic exercise training on plasma levels of tumor necrosis factor alpha in patients with heart failure |
| Q32054917 | Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy |
| Q36964526 | Effects of exercise training on inflammatory markers in patients with heart failure |
| Q44210751 | Effects of pentoxifylline on cytokine profiles and left ventricular performance in patients with decompensated congestive heart failure secondary to idiopathic dilated cardiomyopathy |
| Q57396400 | Elevated serum and monocyte tumour necrosis factor alpha in patients with congestive heart failure |
| Q74194624 | Enhanced gene expression of chemokines and their corresponding receptors in mononuclear blood cells in chronic heart failure--modulatory effect of intravenous immunoglobulin |
| Q80393560 | Expression of interferon-gamma and interleukin-4 production in CD4+ T cells in patients with chronic heart failure |
| Q34154732 | Free radicals, cytokines and nitric oxide in cardiac failure and myocardial infarction |
| Q42696824 | Heart-kidney crosstalk and role of humoral signaling in critical illness |
| Q43640444 | Hematopoiesis/erythropoiesis in myocardial infarcts |
| Q97644840 | Hemorheological Alterations in Patients with Heart Failure with Reduced Ejection Fraction Treated by Resveratrol |
| Q37004826 | How can we cure a heart "in flame"? A translational view on inflammation in heart failure |
| Q37200229 | IL-6 loss causes ventricular dysfunction, fibrosis, reduced capillary density, and dramatically alters the cell populations of the developing and adult heart |
| Q38598201 | IL-6 signalling in patients with acute ST-elevation myocardial infarction |
| Q36436336 | Immunomodulatory effects of cardiotrophin-1 on in vitro cytokine production of monocytes & CD4 + T-lymphocytes |
| Q34748917 | Increase of plasma IL-9 and decrease of plasma IL-5, IL-7, and IFN-γ in patients with chronic heart failure |
| Q35756990 | Inflammation and chronic heart failure-potential therapeutic role of intravenous immunoglobulin |
| Q37090971 | Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology |
| Q36204135 | Inflammatory Biomarkers in Refractory Congestive Heart Failure Patients Treated with Peritoneal Dialysis |
| Q37891878 | Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome |
| Q37775559 | Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation |
| Q33862362 | Inflammatory mediators in heart failure |
| Q38393039 | Innate immunity and the failing heart: the cytokine hypothesis revisited |
| Q34027444 | Insights into pathogenesis and treatment of cytokines in cardiomyopathy |
| Q35583476 | Insulin resistance and inflammatory activation in older patients with systolic and diastolic heart failure |
| Q39343678 | Interleukin 6(-174G/C) variant and its circulating levels in coronary artery disease patients and their first degree relatives |
| Q44240016 | Interleukin-6 and tumor necrosis factor-alpha levels increase in response to maximal exercise in patients with chronic heart failure |
| Q38183314 | Interleukin-6 signaling, soluble glycoprotein 130, and inflammation in heart failure |
| Q35742253 | Is too much neurohormonal blockade harmful? |
| Q49555073 | JNK and NF-κB signaling pathways are involved in cytokine changes in patients with congenital heart disease prior to and after transcatheter closure |
| Q33886486 | Lack of chemokine signaling through CXCR5 causes increased mortality, ventricular dilatation and deranged matrix during cardiac pressure overload |
| Q27340146 | Left Ventricular T-Cell Recruitment Contributes to the Pathogenesis of Heart Failure. |
| Q52020260 | Leukemia inhibitory factor is augmented in the heart in experimental heart failure. |
| Q34398672 | Low-level laser therapy improves the inflammatory profile of rats with heart failure |
| Q94595715 | Macrophage Activities in Myocardial Infarction and Heart Failure |
| Q34443742 | Managing heart failure with immunomodulatory agents |
| Q33921392 | Molecular determinants of the cardiometabolic phenotype |
| Q39094397 | Molecular mechanism of sarcopenia and cachexia: recent research advances. |
| Q37638247 | Morphological and molecular changes of the myocardium after left ventricular mechanical support |
| Q43853610 | Myocardial tumor necrosis factor-alpha expression does not correlate with clinical indices of heart failure in patients on left ventricular assist device support |
| Q40964343 | Neurohumoral improvement and torsional dynamics in patients with heart failure after treatment with levosimendan. |
| Q47365279 | New methodologies to accurately assess circulating active transforming growth factor-β1 levels: implications for evaluating heart failure and the impact of left ventricular assist devices |
| Q36666482 | Novel and potential future biomarkers for assessment of the severity and prognosis of chronic heart failure : a clinical review |
| Q33572474 | Nutrition intervention to decrease symptoms in patients with advanced heart failure |
| Q36951691 | Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease. |
| Q34493636 | Optimizing the parameters of vagus nerve stimulation by uniform design in rats with acute myocardial infarction |
| Q56839437 | Plasma interleukin-4, interleukin-10, and interleukin-13 concentrations and complications after coronary artery bypass graft surgery |
| Q87028013 | Polymorphisms of tumor necrosis factor-alpha and interleukin-6 gene and C-reactive protein profiles in patients with idiopathic dilated cardiomyopathy |
| Q73200629 | Possible role of proinflammatory cytokines in heart allograft coronary artery disease |
| Q79322013 | Prognostic value of interleukin-6, plasma viscosity, fibrinogen, von Willebrand factor, tissue factor and vascular endothelial growth factor levels in congestive heart failure |
| Q35174397 | Reduced cardiorespiratory fitness after stroke: biological consequences and exercise-induced adaptations. |
| Q35082716 | Relationship between dietary folate intake and plasma monocyte chemoattractant protein-1 and interleukin-8 in heart failure patients |
| Q34134804 | Remote ischemic conditioning improves coronary microcirculation in healthy subjects and patients with heart failure |
| Q47968070 | Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial |
| Q38134311 | Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target |
| Q36806972 | Role of inflammation in the progression of heart failure |
| Q42027456 | Role of soluble gp130 in the tumour necrosis factor-alpha expression and its production by peripheral blood mononuclear cells |
| Q33942433 | Salt intake is associated with inflammation in chronic heart failure. |
| Q73400592 | Serum but not myocardial TNF-α concentration is increased in pacing-induced heart failure in rabbits |
| Q24307293 | Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis |
| Q92644753 | Synergistic effect of estradiol and testosterone protects against IL-6-inducedcardiomyocyte apoptosismediated by TGF-β1 |
| Q36526913 | Systemic inflammation in heart failure--the whys and wherefores |
| Q63880217 | TGF-β1 Gene polymorphisms in patients with end-stage heart failure |
| Q37997644 | TNF revisited: osteoprotegerin and TNF-related molecules in heart failure |
| Q37767172 | TNFα in myocardial ischemia/reperfusion, remodeling and heart failure |
| Q42916626 | The Beneficial Effect of n-3 Polyunsaturated Fatty Acids on Doxorubicin-induced Chronic Heart Failure in Rats |
| Q37687213 | The G-308A polymorphism of the TNF-alpha gene does not predict changes in cardiac function in response to medical therapy for idiopathic dilated cardiomyopathy. |
| Q59333262 | The Inflammatory Response to Ventricular Assist Devices |
| Q92434958 | The circulating level of interleukins 6 and 18 in ischemic and idiopathic dilated cardiomyopathy |
| Q30320708 | The enhanced plasma levels of soluble tumor necrosis factor receptors (sTNF-R1; sTNF-R2) and interleukin-10 (IL-10) in patients suffering from chronic heart failure are reversed in patients treated with beta-adrenoceptor antagonist |
| Q38254130 | The hemodynamic and nonhemodynamic crosstalk in cardiorenal syndrome type 1. |
| Q38051119 | The immunological axis in heart failure: importance of the leukocyte differential |
| Q79211153 | The incidence of new onset congestive heart failure and heart failure exacerbation in Veteran's Affairs patients receiving tumor necrosis factor alpha antagonists |
| Q35145655 | The relationship between late gadolinium enhancement imaging and myocardial biopsy in the evaluation of chronic heart failure patients with suspected myocarditis. |
| Q37532701 | The relationship of pro-inflammatory markers to vascular endothelial function after acute stroke. |
| Q38091933 | The role of B-cells in heart failure |
| Q33824143 | The role of inflammatory mediators in chronic heart failure: cytokines, nitric oxide, and endothelin-1. |
| Q34222978 | The role of interleukin-6 in the failing heart |
| Q28214190 | The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases |
| Q47804308 | Time Course of Flow-Mediated Dilation and Vascular Endothelial Growth Factor following Acute Stroke |
| Q34084312 | Transforming growth factor beta-1 and incidence of heart failure in older adults: the Cardiovascular Health Study |
| Q37192858 | Tumor necrosis factor-alpha and mortality in heart failure: a community study |
| Q86595855 | Ultrasound modulates skeletal muscle cytokine levels in rats with heart failure |
| Q35578732 | Vitamin D deficiency contributes to the reduction and impaired function of naïve CD45RA⁺ regulatory T cell in chronic heart failure |
| Q33799421 | Wnt5a is associated with right ventricular dysfunction and adverse outcome in dilated cardiomyopathy |
| Q74043498 | [New pharmacological agents in heart failure] |
Search more.